The world has experienced the COVID-19 pandemic since late 2019, and evidence-based research on new interventions for the life-threatening disease is in high demand. In fact, while we have not seen a pandemic at this scale for about a century, regional epidemics of emerging infectious diseases have never stopped. Just in the past two decades, we have experienced regional outbreaks of SARS, Ebola, MERS, Zika, Avian Influenza H5N1 and H7N9, COVID-19, etc., and drug resistance issues with TB, HIV, Influenza A/B, etc. create new challenges in disease prevention and control. There has been an increasing amount of research related to COVID-19 interventions in recent months, together with many other articles addressing critical issues in the interventions of other emerging or re-circulating infectious diseases. Therefore, this Research Topic will provide a timely literature foundation for future endeavors in combating the many emerging infectious diseases.
In the past two decades, we have experienced regional outbreaks of emerging and re-circulating infectious diseases including SARS, Ebola, MERS, Zika, Avian Influenza H5N1 and H7N9, and are currently going through a pandemic of COVID-19. The goal of this article collection is to provide a timely literature foundation for future endeavors in developing new interventions for emerging infectious diseases, with the consideration of drug resistance issues in existing interventions.
This Research Topic will accept manuscripts included, but not limited to:
• Review articles on the interventions of emerging infectious diseases
• New intervention clinical trials
• Cohort or case control studies reporting on promising associations between new interventions and disease outcomes
• Studies on drug resistance issues with existing interventions
• Intervention safety and adverse outcomes for emerging infectious disease treatment
• Evidence-based research on applying established interventions for existing diseases to newly emerging infectious diseases
The world has experienced the COVID-19 pandemic since late 2019, and evidence-based research on new interventions for the life-threatening disease is in high demand. In fact, while we have not seen a pandemic at this scale for about a century, regional epidemics of emerging infectious diseases have never stopped. Just in the past two decades, we have experienced regional outbreaks of SARS, Ebola, MERS, Zika, Avian Influenza H5N1 and H7N9, COVID-19, etc., and drug resistance issues with TB, HIV, Influenza A/B, etc. create new challenges in disease prevention and control. There has been an increasing amount of research related to COVID-19 interventions in recent months, together with many other articles addressing critical issues in the interventions of other emerging or re-circulating infectious diseases. Therefore, this Research Topic will provide a timely literature foundation for future endeavors in combating the many emerging infectious diseases.
In the past two decades, we have experienced regional outbreaks of emerging and re-circulating infectious diseases including SARS, Ebola, MERS, Zika, Avian Influenza H5N1 and H7N9, and are currently going through a pandemic of COVID-19. The goal of this article collection is to provide a timely literature foundation for future endeavors in developing new interventions for emerging infectious diseases, with the consideration of drug resistance issues in existing interventions.
This Research Topic will accept manuscripts included, but not limited to:
• Review articles on the interventions of emerging infectious diseases
• New intervention clinical trials
• Cohort or case control studies reporting on promising associations between new interventions and disease outcomes
• Studies on drug resistance issues with existing interventions
• Intervention safety and adverse outcomes for emerging infectious disease treatment
• Evidence-based research on applying established interventions for existing diseases to newly emerging infectious diseases
